The Pineal Gland in Multiple Sclerosis

References

• Abo T., Kawate T., Itoh K., Kumagai K. Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B and K cell traffic in the peripheral blood. Journal of Immunology 1981; 126: 1360–1363
   PubMed Web of Science ®Google Scholar
• Adams R. D., Victor M. Principles of neurology. McGraw-Hill Book Company, New York 1985; 699–717
   Google Scholar
• Adeloye A., Felson B. Incidence of normal pineal gland calcification in skull roent-geno-grams of black and white Americans. American Journal of Radiology 1974; 122: 503–507
   Google Scholar
• Ader R. Psychoneuroimmunology. Academic Press, New York 1981
   Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Arias Bal M. A., Vazquez-Barquero J. L., Pena C, Miro J., Berciano J. A. Psychiatric aspects of multiple sclerosis. Acta Psychiatric Scandinavica 1991; 83: 292–296
   PubMed Web of Science ®Google Scholar
• Bamford C. R., Sibley W. A., Thies C. Seasonal variations of multiple sclerosis exacerbations in Arizona. Neurology 1983; 33: 697–701
   PubMed Web of Science ®Google Scholar
• Birau N. Melatonin in human serum: progress in screening investigation and clinic. Melatonin: current status and perspectives, N. Birau, Schlott (Eds.). W. Pergamon, Oxford 1981
   Google Scholar
• Champney T. H., Brainard G.C, Richardson B. A., Reiter R. J. Experimentally-induced diabetes reduces nocturnal pineal melatonin content in the Syrian hamster. Comparative Biochemistry and Physiology 1983; 76A: 199–201
   Google Scholar
• Chiba M., Yamada M. About calcification of the pineal gland in Japanese. Foliopsychiatry Neurology Japan 1948; 2: 301–303
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Dalos N. P., Rabins P. V., Brooks B. R. Disease activity and emotional state in multiple sclerosis. Annals of Neurology 1983; 13: 573–577
   PubMed Web of Science ®Google Scholar
• Daramola G. F., Olowu A. O. Physiological and radiological implications of a low incidence of pineal calcification in Nigeria. Neuroendocrinology 1972; 9: 41–57
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C, Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in which South African-born and in white immigrants to South Africa. British Medical Journal 1967; 2: 724–730
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P., Catalanotto F., Donaldson J. O., Ostrom K. M., Testa M. A. Zinc in multiple sclerosis. Annals of Neurology 1983; 14: 450–454
   PubMedGoogle Scholar
• Dyke C. G. Indirect signs of brain tumor as noted in routine roentgen examinations: Displacement of the pineal shadow; A survey of 3,000 consecutive skull examinations. American Journal of Radiology 1930; 23: 598–606
   Google Scholar
• Elian M., Dean G. Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies. Journal of Neurology, Neurosurgery, and Psychiatry 1987; 50: 327–332
   PubMedGoogle Scholar
• Frick E., Scheid-Seydel L. Untersuchungen mit markirtem Globulin zur Frage der Abstam-mung der Liquoreiweisskorper. Klinische Wochenschrift 1958; 36: 857–863
   PubMedGoogle Scholar
• Garfield D. A. S. Multiple sclerosis and affective disorder: 2 case reports of mania with psychosis. Psychotherapy & Psychosomatics 1985; 44: 25–33
   PubMed Web of Science ®Google Scholar
• Goodstein R. K., Ferrell R. B. Multiple sclerosis presenting as depressive illness. Diseases of the Nervous System 1977; 38: 127–131
   PubMedGoogle Scholar
• Gorray K.C, Quay R. B. L., Ewart R. B. L. Effects of pinealectomy and pineal incubation medium and sonicates on insulin release by isolated pancretic islets in vitro. Hormone Metabolic Research 1979; 11: 432–436
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Jankovic B. D., Maric D., Ranin J., Veljic J. Magnetic fields, brain and immunity: effect on humoral and cell-mediated immune responses. International Journal of Neuroscience, in press
   Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Joffe R. T., Lippert G. P., Gray T. A. Mood disorder and multiple sclerosis. Archives of Neurology 1987; 44: 376–378
   PubMed Web of Science ®Google Scholar
• Kahana E., Leibowitz W. Alter. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–1185
   PubMed Web of Science ®Google Scholar
• Kellner C. H., Davenport Y., Post R. M., Ross R. J. Rapidly cycling bipolar disorder and multiple sclerosis. American Journal of Psychiatry 1984; 141: 112–113
   PubMed Web of Science ®Google Scholar
• Kisser W., Harrcr G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F., Beebe G. W., Norman J. E. Epidemiology of multiple sclerosis in US veterans I. Race, sex, and geographic distribution. Neurology 1979; 29: 1228–1235
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., Rosenthal N. E. Manic depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Nurnberger J. I., Wehr T. A., Pack D., Becker L. E., Powell R. L., Newsome D. A. Supersensitivity to light: Possible trait marker for manic depressive illness. American Journal of Psychiatry 1985; 142: 752–727
   PubMedGoogle Scholar
• Macpherson P., Mathcson M. S. Comparison of calcification of pineal, habenular commissure and choroid plexus in plain films and computed tomography. Neuroradiology 1979; 18: 67–72
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987a; 496: 61–17
   Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 277–279
   Google Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• Matthews W. B., Acheson E. D., Batchelor J. R., Weller R. O. McAlpines multiple sclerosis. Churchill Livingstone, Edinburgh 1985
   Google Scholar
• McFarlin D. E., McFarland H. Multiple sclerosis. New England Journal of Medicine 1982; 307: 1183–1188
   PubMed Web of Science ®Google Scholar
• Milcu S. M., Nanu-lonescu I., Milcu I. The effect of pinealectomy on plasma insulin in rats. The pineal gland, G. E. W. Wolstenholme, Knight (Eds.). J. Churchill-Livingstone, London 1971; 345–360
   Google Scholar
• Mohr J. P. Multiple sclerosis. Manual of clinical problems in neurology, J. P. Mohr. Little Brown, Boston 1984; 273–277
   Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Norman J. E., Kurtzke J. F., Beebe G. W. Epidemiology of multiple sclerosis in US veterans 2. Latitude, climate and the risk of multiple sclerosis. Journal of Chronic Disease 1983; 36: 551–560
   PubMedGoogle Scholar
• Pang S. F., Tang F., Tang P. L. Alloxan-induced diabetes and the pineal gland: differential effects on the levels of pineal N-acetylserotonin, pineal melatonin, and serum melatonin. Journal of Pineal Research 1985; 2: 79–85
   PubMed Web of Science ®Google Scholar
• Pelham R. W., Vaughan G. M., Sandock K. L., Vaughan M. K. Twenty-four-hour cycle of a melatonin-like substance in the plasma of human males. Clinical Endocrinology 1973; 37: 341–344
   Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 165–175
   PubMed Web of Science ®Google Scholar
• Poser C. M., Paty D. W., Scheinberg L. New diagnostic criteria for multiple sclerosis; guidelines for research protocols. Annals of Neurology 1983; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Laboratory Investigations 1978; 38: 409–421
   PubMed Web of Science ®Google Scholar
• Reiter R. J. The pineal gland. Raven Press, New York 1984
   Google Scholar
• Schiffer R. B. The spectrum of depression in multiple sclerosis. An approach for clinical management. Archives of Neurology 1987; 44: 596–599
   PubMedGoogle Scholar
• Schiffer R. B., Caine E. D., Bamford K. A. Depressive episodes in patients with multiple sclerosis. American Journal of Psychiatry 1983; 140: 1498–1500
   PubMed Web of Science ®Google Scholar
• Schiffer R. B., Babigian H. M. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: an epidemiologic study. Archives of Neurology 1984; 41: 1067–1069
   PubMed Web of Science ®Google Scholar
• Schiffer R. B., Wineman N. M., Weitkamp L. R. Association between bipolart affective disorder and multiple sclerosis. American Journal of Psychiatry 1986; 143: 94–95
   PubMed Web of Science ®Google Scholar
• Shibasaki H. Clinical and epidemiological aspects of multiple sclerosis in Asia. Progress in Clinical Neurosciences 1985; 2: 56–64
   Google Scholar
• Sonninen V., Riekkinen P., Rinne J. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stewart J. W., Halbreich U. Plasma melatonin levels in depressed subjects before and after treatment with antidepressant medications. Biological Psychiatry 1989; 25: 33–38
   PubMed Web of Science ®Google Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Trentini G. P., De Gaetani S. F., Criscuolo M., Migaldi M., Ferrari G. Pineal calcification in different physiopathological conditions in humans. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, Pevet (Eds.). P. Raven Press, New York 1987; 291–304
   Google Scholar
• Waksman B. H., Reynolds W. E. Multiple sclerosis as a disease of immune regulation. Proceedings of the Society of Experimental Biology and Medicine 1984; 175: 282–294
   PubMed Web of Science ®Google Scholar
• Warren S., Warren K. G. Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Canadian Journal of Neurological Sciences 1981; 8: 35–39
   PubMed Web of Science ®Google Scholar
• Warren S. A., Warren K. G. Multiple sclerosis and diabetes mellitus: Further evidence for a relationship. Canadian Journal of Neurological Sciences 1982; 11: 415–419
   Google Scholar
• Weichelbaum R., Patel M., Das Gupta T. K. Influence of the pineal on wound healing. Nature 1975; 254: 349
   PubMedGoogle Scholar
• Weiner H. L., Hauser S. L. Neuroimmunology. I: Immunoregulation in neurological disease. Annals of Neurology 1982; 11: 437–449
   PubMed Web of Science ®Google Scholar
• Weinschenker B. G., Ebers G. C. The natural history of multiple sclerosis. Canadian Journal of Neurological Sciences 1987; 14: 255–261
   PubMed Web of Science ®Google Scholar
• Whitlock F. A., Siskind M. M. Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1980; 43: 861–865
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Wong P. Y., Fritze L. Determination by neutron activation of Cu, Mn and zinc in the pineal body and other areas of the brain tissue. Journal of Neurochemistry 1969; 16: 1231–1234
   PubMed Web of Science ®Google Scholar
• Wong E. K., Enomoto H., Leopold I. H., Fleischer E. R., Schoon E. U., Fender O., Tucker H. G., Adamson B., Kladde, Kazan L.D., Nudleman K. Plasma zinc levels in multiple sclerosis. Metabolic Pediatric Opthalmology 1980; 4: 3–8
   PubMedGoogle Scholar
• Wuthrich R., Rieder H. P. The seasonal incidence of mutiple sclerosis in Switzerland. European Neurology 1970; 3: 257–264
   PubMed Web of Science ®Google Scholar